ABG-WTT Global Life Science Capital Partners GP Ltd — Q2 2023 13F-HR

← ABG-WTT Global Life Science Capital Partners GP Ltd

Q2 2023 · 13F-HR

ABG-WTT Global Life Science Capital Partners GP Ltdholdings as filed

Filed 2023-08-14 · accession 0000950123-23-008200

$5.5M

Reported value

Positions

2023-06-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
58406B103	—	MEDAVAIL HOLDINGS INC	$3.7M	66.8%	15,029,480	Common	SOLE
75340L104	RPID	RAPID MICRO BIOSYSTEMS INC	$1.0M	18.8%	1,038,296	Common	SOLE
745848101	LUNG	PULMONX CORP	$789,274	14.3%	60,204	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.